Advertisement

Calcified Tissue International

, Volume 45, Issue 2, pp 71–73 | Cite as

Suggestion of a deficient osteoblastic function in diabetes mellitus: The possible cause of osteopenia in diabetics

  • H. Rico
  • E. R. Hernandez
  • J. A. Cabranes
  • F. Gomez-Castresana
Clinical Investigation

Summary

The mechanism underlying diabetic osteopenia is still unclear and may involve osteoblastic activity and/or the deficit of insulin's anabolic action. Bone gla protein (BGP) is synthesized by the osteoblast and its synthesis increases with 1,25(OH)2D3 and fluoride. Because 1,25(OH)2D3 also stimulates insulin secretion, sodium fluoride administration can be used to investigate deficient osteoblastic activity in diabetics, as reflected by BGP levels. BGP was determined before and after administering sodium fluoride at a dosage of 50 mg/day/15 days to three groups: 14 patients with insulin-dependent diabetes, 16 diabetics on oral antidiabetic treatment, and 25 controls, all of similar age, sex, and characteristics. Basal BGP values (mean±SD) were low in diabetics on insulin treatment (4.3±1.1 ng/ml) and in diabetics on oral antidiabetics (5.8±1.2 ng/ml) as compared with controls (6.5±0.7 ng/ml) (P<0.001 and <0.05, respectively). After giving fluoride, BGP values did not change in the two diabetic groups but did vary in controls (8.1±0.6 ng/ml,P<0.001). These results suggest that deficient osteoblast function could be responsible for osteopenia in diabetics.

Key words

Diabetes mellitus Osteocalcin Sodium fluoride Osteoblast Diabetic osteopenia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hough S, Avioli LV (1984) Alterations of bone mineral metabolism in diabetes. In: Nattrass M, Santiago JV (eds) Recent advances in diabetes. Churchill Livingstone, New York, pp 223–229Google Scholar
  2. 2.
    Schneider LE, Sheld HP, McCain T, Haussler MR (1977) Experimental diabetes reduced circulating 1,25-dyhidroxyvitamin D in the rat. Science 196:1452–1454PubMedCrossRefGoogle Scholar
  3. 3.
    Scheldt HP, Heath H, Wenger J (1978) Serum calcitonin and parathyroid hormone in experimental diabetes: effects of insulin treatment. Endocrinology 103:1368–1373Google Scholar
  4. 4.
    Heath H, Lambert PW, Service FJ, Arnaud SB (1979) Calcium homeostasis in diabetes mellitus. J Clin Endocrinol Metab 49:462–466PubMedGoogle Scholar
  5. 5.
    Klein M, Frost HM (1964) The numbers of bone resorption and formation in rib. Henry Ford Hos Med Bull 12:527–536Google Scholar
  6. 6.
    Canalis EM, Dietrich JW, Maina DM, Raisz LG (1977) Hormonal control of bone collagen synthesis in vitro: effects of insulin and glucagon. Endocrinology 100:668–674PubMedCrossRefGoogle Scholar
  7. 7.
    Nishimoto SK, Price PA (1979) Proof that the gammacarboxyglumatic acid-containing bone protein is synthesized in calf bone. J Biol Chem 254:437–441PubMedGoogle Scholar
  8. 8.
    Rico H, Cabranes JA, Hernandez ER, Almoguera I (1987) Valores de osteocalcina en la diabetes mellitus y sus variaciones segun el tratamiento. Med Clin (Barc) 88:798–800Google Scholar
  9. 9.
    Palumeri E, Pedrazzoni M, Malaquino AM, Carapezzi C, Carbognani A, Maroni L (1984) Osteocalcin levels in diabetes mellitus. In: Christiansen C, Arnaud CD, Parfitt AM, Peck WA, Riggs L, (eds) Osteoporosis. Aalborg Stiftsbogtrykkeri, Denmark, pp 809–810Google Scholar
  10. 10.
    Wientroub S, Price PA, Reddi AH (1987) The dichotomy in the effects of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on bone gamma-carboxyglutamic acid-containing protein in serum and bone in vitamin D-deficient rats. Calcif Tissue Int 40:166–172PubMedCrossRefGoogle Scholar
  11. 11.
    Delmas PD, Malaval L (1987) New biochemical markers of bone turnover. In: Cohn DV, Martin TJ, Meunier PJ (eds) Calcium regulation and bone metabolism: basic and clinical aspects, vol. 9. Elsevier Science Publisher, Amsterdam, pp 105–112Google Scholar
  12. 12.
    Beresford JN, Gallagher JA, Poser JW, Russell RGG (1984) Production of osteocalcin by human cells in vitro. Metab Bone Dis Rel Res 5:229–234CrossRefGoogle Scholar
  13. 13.
    Gundberg CM, Anderson M, Dickson I, Gallop PM (1986) “Glicated” osteocalcin in human and bovine bone. J Biol Chem 261:14557–14561PubMedGoogle Scholar
  14. 14.
    Garlick RL, Mazer JS, Higgins PJ, Bunn HF (1983) Characterization of glycosylated hemoglobins. J Clin Invest 71:1062–1072PubMedGoogle Scholar
  15. 15.
    Snow GR, Anderson C (1986) Short-term chronic fluoride administration and trabecular bone remodeling in Beagles: a pilot study. Calcif Tissue Int 38:217–221PubMedCrossRefGoogle Scholar
  16. 16.
    Duda RJ, Jumar R, Nelson KI, Zinsmeister AR, Mann KG, Riggs BL (1987) 1,25-dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women. J Clin Invest 79:1249–1253PubMedCrossRefGoogle Scholar
  17. 17.
    Perlish JS, Bashey R, Lleischmajer R (1973) The in vitro effect of insulin on collagen synthesis in embryon chick tibia. Proc Soc Exp Biol Med 142:1152–1154PubMedGoogle Scholar
  18. 18.
    Berney PW (1952) Osteoporosis and diabetes mellitus. J Iowa Med Soc 42:10–12PubMedGoogle Scholar
  19. 19.
    Shore RM, Chesney RW, Mazess RB, Rose P, Bargman GJ (1981) Osteopenia in juvenile diabetes. Calcif Tissue Int 33:455–457PubMedCrossRefGoogle Scholar
  20. 20.
    Roth J, Prout TE, Goldfine ID (1971) Sulphonylureas: effects in vivo and in vitro. Ann Intern Med 75:607–621Google Scholar
  21. 21.
    Levin ME, Boisseau VC, Avioli LV (1976) Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med 294:241–245PubMedCrossRefGoogle Scholar
  22. 22.
    Riggs BL, Mann KG (1987) Assessment of bone turnover in osteoporosis using biochemical markers. In: Christiansen C, Johansen JS, Riis BJ (eds) Osteoporosis 1987. Osteopres ApS, Denmark, pp 672–676Google Scholar
  23. 23.
    Lian JB, Gundberg CM (1988) Osteocalcin. Clin Orthop 226:267–291PubMedGoogle Scholar
  24. 24.
    Seibold JR, Uitto J, Dorwart BB, Prockop DJ (1985) Collagen synthesis and collagenase activity in dermal fibroblast and digital sclerosis. J Lab Clin Med 105:664–667PubMedGoogle Scholar
  25. 25.
    Landeros O, Frost HF (1964) Radial rate of osteon closure measured by means of tetracycline labelling. Henry Ford Hosp Med Bull 12:499–507Google Scholar
  26. 26.
    Goodman WG, Hori MT (1984) Diminished bone formation in experimental diabetes. Diabetes 33:825–831PubMedGoogle Scholar
  27. 27.
    Aubia J, Serrano S, Marinoso LL, Hojman L, Diez A, Lloveras J, Masramon J (1988) Osteodystrophy of diabetics in chronic dialysis: a histomorphometric study. Calcif Tissue Int 42:297–301PubMedCrossRefGoogle Scholar
  28. 28.
    Goldstein S, Littlefield JW, Soeldner JS (1969) Diabetes mellitus and aging: diminished plating efficiency of cultured human fibroblast. Proc Natl Acad Sci USA 64:155–160PubMedCrossRefGoogle Scholar
  29. 29.
    Levy-Marchal C, Laborde K, Souberbielle JC, Kindermans C, Gouget B, Sachs CH, Czernichow P (1986) Bone and mineral metabolism in young children with insulin-dependent diabetes mellitus (IDDM). Transplant Proc 15:1501Google Scholar
  30. 30.
    Avioli LV (1977) Osteoporosis: pathogenesis and therapy. In: Avioli LV, Krane SM (eds) Metabolic bone disease. Academic Press, New York, pp 307–385Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1989

Authors and Affiliations

  • H. Rico
    • 1
  • E. R. Hernandez
    • 1
  • J. A. Cabranes
    • 1
  • F. Gomez-Castresana
    • 1
  1. 1.Department of Internal Medicine, Medical SchoolUniversidad de Alcalá de HenaresMadridSpain

Personalised recommendations